Fact Source: Financial Supervisory Service DART
💡 Executive Summary
Hana Micron decided on a new facility investment worth KRW 68.62 billion (12.98% of total equity) for semiconductor test equipment to expand capacity for the non-memory test market.
📊 Key Disclosure Content & Financial Figures Summary
- Company Name: Hana Micron Inc.
- Investment Type: Facility Investment (Semiconductor TEST Equipment)
- Investment Details:
- Investment Amount: KRW 68,618,380,000 (USD 50,200,000 / Exchange rate KRW 1,366.90/USD)
- Total Equity: KRW 528,822,169,638 (Based on FY2023 consolidated statements including capital changes up to filing date)
- Ratio to Total Equity: 12.98%
- Investment Purpose: Securing additional production capacity to respond to the non-memory TEST market
- Investment Period: July 1, 2024 ~ January 31, 2025 (Based on payment dates)
- Board Resolution Date: June 10, 2024 (1 Outside Director attended, Auditor attended)
- Other References for Investment Decision:
- Equipment delivery is scheduled sequentially from July 2024 to December 2024.
- The investment amount in KRW may vary depending on foreign exchange rates at actual import dates.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Investment Scale and Execution Schedule
This disclosure announces a decision to invest in semiconductor TEST equipment to secure production capacity in the non-memory test market. Checking the investment scale (approx. KRW 68.62 billion) and execution schedule (investment period July 1, 2024 ~ January 31, 2025; equipment delivery July–December 2024) is necessary. Further details can be verified through this disclosure and the Korea Exchange KIND system.
📢 Disclaimer & Source Information
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Disclaimer: This content is provided solely for information purposes and linguistic reference. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial risks rest solely with the investor.
Contact: For compliance inquiries or copyright-related issues, please contact ksb220805@gmail.com.
